Genome-Wide Association Study to Identify a New Susceptibility Locus for Central Serous Chorioretinopathy in the Japanese Population
Open Access
- 1 November 2018
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 59 (13) , 5542-5547
Abstract
Purpose: Central serous chorioretinopathy (CSC) is a retinal disorder that often affects the vision of middle-aged people yet the molecular mechanisms of CSC remain unknown. This study was conducted to identify genetic factors influencing individual differences in susceptibility to CSC. Methods: A two-stage genome-wide association study (GWAS) was conducted with a total of 320 unrelated Japanese idiopathic CSC cases and 3245 population-based controls. In a discovery stage, 137 unrelated Japanese idiopathic CSC cases and 1174 population-based controls were subjected to GWAS, followed by a replication study using an additional 183 individuals with idiopathic CSC and 2071 population-based volunteers. The results of the discovery and replication stages were combined to conduct a meta-analysis. Results: In the two-stage GWAS, rs11865049 located at SLC7A5 in chromosome 16q24.2 was identified as a novel disease susceptibility locus for CSC, as evident from the discovery and replication results using meta-analysis (combined P = 9.71 × 10−9, odds ratio = 2.10). Conclusions: The results of the present study demonstrated that SLC7A5 might be the potential candidate gene associated with CSC, indicating a previously unidentified molecular mechanism of CSC.Keywords
This publication has 33 references indexed in Scilit:
- Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001–2006: A Population-based StudyPLOS ONE, 2013
- Cellular Localization of Glutamate and Glutamine Metabolism and Transport Pathways in the Rat Ciliary EpitheliumInvestigative Ophthalmology & Visual Science, 2011
- Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells)Journal of Pharmaceutical Sciences, 2010
- The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002Ophthalmology, 2008
- Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: A study involving the in vivo retinal uptake and vitreal pharmacokinetics of l-phenyl alanineInternational Journal of Pharmaceutics, 2007
- Clinical characteristics of subretinal deposits in central serous chorioretinopathyActa Ophthalmologica Scandinavica, 2005
- Expression and Function of Glutamine Transporters SN1 (SNAT3) and SN2 (SNAT5) in Retinal Müller CellsInvestigative Ophthalmology & Visual Science, 2005
- L-Type Amino Acid Transporter 1–Mediatedl-Leucine Transport at the Inner Blood–Retinal BarrierInvestigative Ophthalmology & Visual Science, 2005
- Familial Chronic Central Serous ChorioretinopathyOphthalmologica, 2001
- Systemic findings associated with central serous chorioretinopathyAmerican Journal of Ophthalmology, 1999